1,873
Views
7
CrossRef citations to date
0
Altmetric
Research Papers

Discovery of a novel Aurora B inhibitor GSK650394 with potent anticancer and anti-aspergillus fumigatus dual efficacies in vitro

, , , , , & show all
Pages 109-117 | Received 23 May 2021, Accepted 26 Aug 2021, Published online: 11 Dec 2021

References

  • von Lilienfeld-Toal M, Wagener J, Einsele H, et al. Invasive fungal infection. Dtsch Arztebl Int 2019;116:271–8.
  • Pagano L, Caira M, Candoni A, et al. The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study. Haematologica 2006;91:1068–75.
  • Steinmann J, Hamprecht A, Vehreschild MJ, et al. Emergence of azole-resistant invasive aspergillosis in HSCT recipients in Germany. J Antimicrob Chemother 2015;70:1522–6.
  • Kitzen JJ, de Jonge MJ, Verweij J. Aurora kinase inhibitors. Crit Rev Oncol Hematol 2010;73:99–110.
  • Vader G, Medema RH, Lens SM. The chromosomal passenger complex: guiding Aurora-B through mitosis. J Cell Biol 2006;173:833–7.
  • Ruchaud S, Carmena M, Earnshaw WC. Chromosomal passengers: conducting cell division. Nat Rev Mol Cell Biol 2007;8:798–812.
  • Hsu JY, Sun ZW, Li X, et al. Mitotic phosphorylation of histone H3 is governed by Ipl1/aurora kinase and Glc7/PP1 phosphatase in budding yeast and nematodes. Cell 2000;102:279–91.
  • Andrews PD, Ovechkina Y, Morrice N, et al. Aurora B regulates MCAK at the mitotic centromere. Dev Cell 2004;6:253–68.
  • Zeitlin SG, Shelby RD, Sullivan KF. CENP-A is phosphorylated by Aurora B kinase and plays an unexpected role in completion of cytokinesis. J Cell Biol 2001;155:1147–57.
  • Evans RP, Naber C, Steffler T, et al. The selective Aurora B kinase inhibitor AZD1152 is a potential new treatment for multiple myeloma. Br J Haematol 2008;140:295–302.
  • Wilkinson RW, Odedra R, Heaton SP, et al. AZD1152, a selective inhibitor of Aurora B kinase, inhibits human tumor xenograft growth by inducing apoptosis. Clin Cancer Res 2007;13:3682–8.
  • Ditchfield C, Johnson VL, Tighe A, et al. Aurora B couples chromosome alignment with anaphase by targeting BubR1, Mad2, and Cenp-E to kinetochores. J Cell Biol 2003;161:267–80.
  • Keen N, Taylor S. Aurora-kinase inhibitors as anticancer agents. Nat Rev Cancer 2004;4:927–36.
  • Tanaka S, Arii S, Yasen M, et al. Aurora kinase B is a predictive factor for the aggressive recurrence of hepatocellular carcinoma after curative hepatectomy. Br J Surg 2008;95:611–9.
  • Tatsuka M, Katayama H, Ota T, et al. Multinuclearity and increased ploidy caused by overexpression of the aurora- and Ipl1-like midbody-associated protein mitotic kinase in human cancer cells. Cancer Res 1998;58:4811–6.
  • Otto T, Sicinski P. Cell cycle proteins as promising targets in cancer therapy. Nat Rev Cancer 2017;17:93–115.
  • He JY, Xi WH, Zhu LB, et al. Knockdown of Aurora-B alters osteosarcoma cell malignant phenotype via decreasing phosphorylation of VCP and NF-κB signaling. Tumour Biol 2015;36:3895–902.
  • Yu X, Liang Q, Liu W, et al. Deguelin, an aurora B kinase inhibitor, exhibits potent anti-tumor effect in human esophageal squamous cell carcinoma. EBioMedicine 2017;26:100–11.
  • Dohner H, Muller-Tidow C, Lubbert M, et al. A phase I trial investigating the Aurora B kinase inhibitor BI 811283 in combination with cytarabine in patients with acute myeloid leukaemia. Br J Haematol 2019;185:583–7.
  • Zhao Z, Jin G, Yao K, et al. Aurora B kinase as a novel molecular target for inhibition the growth of osteosarcoma. Mol Carcinog 2019;58:1056–67.
  • Xie H, Lee MH, Zhu F, et al. Identification of an Aurora kinase inhibitor specific for the Aurora B isoform. Cancer Res 2013;73:716–24.
  • Zhu XP, Liu ZL, Peng AF, et al. Inhibition of Aurora-B suppresses osteosarcoma cell migration and invasion. Exp Ther Med 2014;7:560–4.
  • Kantarjian HM, Sekeres MA, Ribrag V, et al. Phase I study assessing the safety and tolerability of barasertib (AZD1152) with low-dose cytosine arabinoside in elderly patients with AML. Clin Lymphoma Myeloma Leuk 2013;13:559–67.
  • Payton M, Bush TL, Chung G, et al. Preclinical evaluation of AMG 900, a novel potent and highly selective pan-aurora kinase inhibitor with activity in taxane-resistant tumor cell lines. Cancer Res 2010;70:9846–54.
  • Yao R, Zheng J, Zheng W, et al. VX680 suppresses the growth of HepG2 cells and enhances the chemosensitivity to cisplatin. Oncol Lett 2014;7:121–4.
  • Gull K, Trinci AP. Griseofulvin inhibits fungal mitosis. Nature 1973;244:292–4.
  • Francisco L, Wang W, Chan CS. Type 1 protein phosphatase acts in opposition to IpL1 protein kinase in regulating yeast chromosome segregation. Mol Cell Biol 1994;14:4731–40.
  • Sherk AB, Frigo DE, Schnackenberg CG, et al. Development of a small-molecule serum- and glucocorticoid-regulated kinase-1 antagonist and its evaluation as a prostate cancer therapeutic. Cancer Res 2008;68:7475–83.
  • Pan H, Lv W, Li Z, et al. SGK1 protein expression is a prognostic factor of lung adenocarcinoma that regulates cell proliferation and survival. Int J Clin Exp Pathol 2019;12:391–408.
  • Orlacchio A, Ranieri M, Brave M, et al. SGK1 is a critical component of an AKT-independent pathway essential for PI3K-mediated tumor development and maintenance. Cancer Res 2017;77:6914–26.
  • Lin H, Zhang D, Zuo K, et al. Structural basis of sequence-specific Holliday junction cleavage by MOC1. Nat Chem Biol 2019;15:1241–8.
  • Lin Z, Jia L, Tomchick DR, et al. Substrate-specific activation of the mitotic kinase Bub1 through intramolecular autophosphorylation and kinetochore targeting. Structure 2014;22:1616–27.
  • Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55–63.
  • Morris GM, Huey R, Lindstrom W, et al. AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem 2009;30:2785–91.
  • Morris GM, Goodsell DS, Halliday RS, et al. Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J Comp Chem 1998;19:1639–62.
  • Elkins JM, Santaguida S, Musacchio A, et al. Crystal structure of human aurora B in complex with INCENP and VX-680. J Med Chem 2012;55:7841–8.
  • Schmidt MW, Baldridge KK, Boatz JA, et al. General atomic and molecular electronic-structure system. J Comp Chem 1993;14:1347–63.
  • Lee C, Yang W, Parr RG. Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density. Phys Rev B Condens Matter 1988;37:785–9.
  • Petersson GA, Bennett A, Tensfeldt TG, et al. A complete basis set model chemistry. I. The total energies of closed‐shell atoms and hydrides of the first‐row elements. J Chem Phys 1988;89:2193–218.
  • Wu Y, Li J, Jiang C, et al. A new small-molecule Aurora B inhibitor shows antitumor activity in human cancer cell lines. Mol Biol Rep 2015;42:517–24.
  • Chowdhary A, Kathuria S, Xu J, et al. Emergence of azole-resistant aspergillus fumigatus strains due to agricultural azole use creates an increasing threat to human health. PLOS Pathog 2013;9:e1003633.
  • Liu W, Wang X, Liu Z, et al. SGK1 inhibition induces autophagy-dependent apoptosis via the mTOR-Foxo3a pathway. Br J Cancer 2017;117:1139–53.